+1.56ãšããæ°åã«é ããããèè ãæç¢ºã«åŠå®ãã誀èªã®æ£äœ
æè¿ãXã§ããããè«æãåºããHPVã¯ã¯ãã³ã矩ååããããŒãžãã¢å·ã§ã¯ãè¥ãäžä»£ã®åå®®é žãããæžãã©ãããéã«å¢ããŠããããšããæçš¿ãèŠãããŠãå¿ãããã€ããæ¹ã¯ããã£ããããŸããããé·å¹Žãåšããã«å§ããŠããã¯ã¯ãã³ãããŸããé广ã ã£ããªããŠãããæããšããããŸã§ã®å€æãééã£ãŠããã®ã§ã¯ãšãäžå®ã«ãªãã®ãåœç¶ã®ããšã ãšç§ã¯æããŸããå®ã¯ç§ãããã®æçš¿ãèŠãç¬éãçã£å ã«åèè«æãéããŸããããããŠåãã£ãã®ã¯ãè«æã®æ°åèªäœã¯ç¢ºãã«æ¬ç©ã§ããäžæ¹ããã®æå³ãSNSäžã§å€§ããããæ²ããããŠãããšããäºå®ã§ãã仿¥ã¯ããã®ããããã©ãã§çãŸããã®ãããäžç·ã«äžå¯§ã«ã»ã©ããŠãããããšæããŸãã
https://www.sciencedirect.com/science/article/pii/S2213538326000780
話é¡ã«ãªã£ãæçš¿ãšãè«æãæ¬åœã«èªã£ãŠããããš
å
æ¥ãXïŒæ§TwitterïŒã§èŠããããã®æçš¿ã«ã¯ãããæžãããŠããŸãããããããè«æåºããHPVã¯ã¯ãã³ã矩ååããããŒãžãã¢å·ã§ã¯è¥è
ã®åå®®é žããã¯æžå°ããéã«å¢å ããŠãããã
å»çã®çŸå Žã«èº«ã眮ãè ãšããŠããããŠå ¬èªå¿çåž«ãšããŠãç§ã¯ãã®æã®æçš¿ãèŠããã³ã«ããŸãäžã€æ·±åŒåžãããŠããåèè«æãéãããšã«ããŠããŸããä»åãããããŸããããããŠèŠããŠããã®ã¯ãæçš¿ãã®ãã®ãçã£èµ€ãªåã§ã¯ãªããšãããå°ãåä»ãªçŸå®ã§ããã
è«æã¯ç¢ºãã«å®åšããŸãïŒ"Causal inference, cancer registry data, and a single state policy change: Evaluating Virginia's HPV vaccine mandate", PubMed ID: 42442540ïŒãç±³åœããŒãžãã¢å·ã2008幎ã«å°å ¥ããã女åã®åŠæ ¡å ¥åŠæHPVã¯ã¯ãã³æ¥çš®çŸ©ååã«ã€ããŠããã®åŸã®åå®®é žãã眹æ£çãžã®åœ±é¿ãæ€èšŒãããã®ã§ãã矩ååã®å¯Ÿè±¡ãšãªã£ãæåã®äžä»£ã20ã24æ³ã«ãªã2016幎以éãåææéãšããå·å¥ã®ããç»é²ããŒã¿ãããšã«ãè€æ°ã®çµ±èšã¢ãã«ã§å¹æãæšå®ããŠããŸãã
äž»èŠãªè§£æã¢ãã«(åæå¯Ÿç §æ³ãçšããããªãã«ã»ãã£ãã¡ã¬ã³ã¹ãå°éçã«ã¯SC-DDDãšåŒã°ããææ³ã§ã)ã§ã¯ã確ãã«ãå¯Ÿç §çŸ€ãšæ¯ã¹ãŠ10äžäººããã+1.56äŸãåå®®é žãããå€ãããšããçµæãåºãŠããŸããããã ããåãåãã°ãæçš¿ã®äž»åŒµã¯æ°åãšããŠã¯ééã£ãŠããŸããã
ããã©ãç§ããã®è«æãèªãã§äžçªå¿ã«æ®ã£ãã®ã¯ããã®å°ãå ã§èè èªèº«ãæžããŠããäžæã§ãããããã¯ã¯ã¯ãã³ãã®ãã®ã®å¹æãåŠå®ãããã®ã§ã¯ãªãããšããã®äžèšã«ãä»åã®ããæ¿ãã®æ£äœããã¹ãŠè©°ãŸã£ãŠãããšãç§ã¯æããŠããŸãã
ãªããååã ãæ¬åœããªã®ãââ3ã€ã®ããæ¿ã
äžã€ã²ãšã€ãäžå¯§ã«ã»ã©ããŠãããŸããããç§ããã®è«æãèªã¿ãªããèŠã€ããã®ã¯ã倧ãã3ã€ã®ããæ¿ãã§ããã
äžã€ç®ã¯ããã¯ã¯ãã³ã®å¹æããšã矩ååãšããæ¿çã®å¹æãã®ããæ¿ãã§ãããã®è«æãæ€èšŒããã®ã¯ãHPVã¯ã¯ãã³ãšããå»è¬åãã®ãã®ã®æå¹æ§ã§ã¯ãããŸãããããŒãžãã¢å·ãå°å ¥ãããåŠæ ¡å ¥åŠæã®æ¥çš®çŸ©ååããšããå¶åºŠããå®éã«æ¥çš®çãæŒãäžãããã®çµæãšããŠå°æ¥ã®ãããæžããããã©ããããšããæ¿çè©äŸ¡ã§ããå®ã¯ããŒãžãã¢å·ã®çŸ©ååã¯ãä¿è·è ã®å€æã«ããå¹ åºããªããã¢ãŠã(å é€)ãèªããŠãããããå¥ã®ç ç©¶(Pierre-Victor D, et al. J Womens Health. 2017)ã§ãã矩ååã®ååŸã§æ¥çš®çã«ææãªå€åãèŠãããªãã£ãããšãå ±åãããŠããŸããã€ãŸããã®è«æã瀺ããã®ã¯ãå¶åºŠãçµµã«æããé€ ã§çµãã£ãŠããå¯èœæ§ãã§ãã£ãŠããã¯ã¯ãã³ãæã£ã人ã«ãããå¢ããããšãã話ã§ã¯ããŸã£ãããªãã®ã§ããã¯ã¯ãã³ãã®ãã®ã®åå®®é žããäºé²å¹æã¯ãäžçååœã®å¥ã®å€§èŠæš¡ç ç©¶ã§ç¹°ãè¿ã確èªãããŠããŸãã
äºã€ç®ã¯ãæ°åã®äžäººæ©ãã§ããå®ã¯ãã®ç ç©¶ãè§£æã¢ãã«ã«ãã£ãŠçµè«ãå€ãããŸããåçŽãªæ¯èŒ(éåžžã®synthetic control DD)ã§ã¯ã矩ååã«ãã广ã¯èªããããŸããã§ããã幎霢矀ããšã®å·å ãã¬ã³ããŸã§å å³ããããã粟緻ãªã¢ãã«(SC-DDD)ã§åããŠããã®+1.56ãšããæ°åãçŸããŸãããããèè èªèº«ããæ¿çå°å ¥åã®æç¹ã§ãã§ã«çŸ€éã®ãã¬ã³ãã«å·®ããã£ãå¯èœæ§(ãããã䞊è¡ãã¬ã³ãã®åæã®äžéšéå)ãèªããåäžå·ã®ããŒã¿ã ãã§å æé¢ä¿ãæå®ããããšã®é£ããããç¹°ãè¿ã泚èšããŠããŸããå ããŠ20ã24æ³ãšãã幎霢局ã®åå®®é žããã¯ããšããšéåžžã«çšãªçŸæ£ã§ãããŒãžãã¢å·ã§ã¯çœ¹æ£æ°ã0äŸã ã£ã幎ãããããŸããå°æ°äŸãæ±ãçµ±èšã¯ãã¡ãã£ãšãããã¬ã§æ°åã倧ããåãããšããè«æãèªã¿è§£ãéã«ç§ããã€ãèã«éããŠããããšã®äžã€ã§ãã
äžã€ç®ã¯ãæèã®æ¬ èœã§ãã20ã24æ³ã®åå®®é žãã眹æ£çãã®ãã®ã¯ãããŒãžãã¢å·ã§ããä»ã®å·ã§ããæéãšãšãã«çå®ã«æžã£ãŠããŸããä»ååé¡ã«ãªã£ã+1.56ãšããæ°åã¯ãããã£ãšæžã£ãŠããŠãããã£ãã¯ããªã®ã«ããã®åã ãå±ããªãã£ãããšããããããŸã§æåŸ å€ãšã®å·®ã衚ããã®ã§ããããããå¢ãããã§ã¯ãªããæåŸ ããã远å ã®äºé²å¹æã瀺ããªãã£ããââãã®äºã€ã¯ã䌌ãŠããããã§ããŸã£ããéã話ã§ãã以åã®èšäºã§ãããæ¥çš®åŸã«äº¡ããªã£ãããšãæ¥çš®ã®ããã§äº¡ããªã£ããããŸã£ããå¥ã®æå³ãæã€ãšãäŒãããŸãããããããšåãæ§é ã®æ··åããä»åãèµ·ããŠããŸãã
ãªãç§ãã¡ã¯ãããããæçš¿ãä¿¡ããŠããŸãã®ã
æ£çŽã«èšããšãå®å
šãªãã¿ã©ã¡ããããããããååã ãæ¬åœãã®æ
å ±ã®ã»ããããã£ãšåä»ã§ããæ¬ç©ã®é£æã䜿ããªãããã¬ã·ãã®æé ã ãã倧ããééããæçã®ãããªãã®ãæ°åãè«æãæ¬ç©ã ãããããç§ãã¡èªèº«ã®ç®ã§çްéšã確ãããªãéããç°¡åã«ã¯èŠæããŸããã
ããçµ±èšåŠè ã®æåãªèŠå¥ã«ããããªèšèããããŸããåã«ã¯äžçš®é¡ãããåãšã倧åãšããããŠçµ±èšã ããã®èšèãé·ãèªãç¶ãããŠããã®ã¯ãæ£ç¢ºãªæ°åã§ãã£ãŠããåãåãæ¹ã²ãšã€ã§å°è±¡ããŸã£ããå€ãã£ãŠããŸããšããã人éã®å¿çã®åŒ±ããç確ã«çªããŠããããã ãšãç§ã¯æããŸãã
ç§ãã¡ã®è³ã¯ãã·ã³ãã«ã§ææ ãæºãã¶ãç©èªã®ã»ãããè€éã§æ éãªç©èªãã奜ãã§åãå ¥ããŠããŸãåŸåããããŸãããã¯ã¯ãã³ãåå®®é žãããå¢ãããããšããäžæã¯ãææãšæãããŸãšã£ããæ¡æ£åã®åŒ·ãç©èªã§ããäžæ¹ã§ãåäžå·ã®æ¿çå®è£ ããæåŸ ããã广ãçºæ®ã§ããªãã£ãå¯èœæ§ãããããšããæ£ç¢ºãªçµè«ã¯ãå°å³ã§ãæããã·ã§ã¢ããããªããããªåºæ¿ããããŸãããSNSã®ã¢ã«ãŽãªãºã ã¯ãæ®å¿µãªããåŸè ãããåè ããã¯ããã«é ããŸã§éãã§ããŸãã®ã§ãã
ããã«æ¯ãåãããªãããã®3ã€ã®èŠç¹
ããããæçš¿ã«åºäŒã£ããšããç§ãå®éã«èªåèªèº«ãžåããããŠããèŠç¹ãã3ã€ã ãå
±æãããŠãã ããã
äžã€ç®ã¯ãããã¯ç©ãã®ãã®ã®è©±ãããããšãå¶åºŠã»éçšã®è©±ããåããŠèããããšã§ããã¯ã¯ãã³ãšããç©è³ªã®æå¹æ§ãšã矩ååãšããå¶åºŠã®å®è¡åã¯ããŸã£ããå¥ã®åé¡ã§ãã
äºã€ç®ã¯ããã®æ°åã¯ãã©ã®åæã»ã©ã®ã¢ãã«ã«åºã¥ããã®ãã確èªããããšã§ããåãããŒã¿ã§ããã¢ãã«ã®åãæ¹æ¬¡ç¬¬ã§çµè«ãå€ããããšã¯ã決ããŠçãããããŸããã
äžã€ç®ã¯ã絶察æ°ã¯å¢ããŠããã®ããæžã£ãŠããã®ããèŠãããšã§ããä»åã®ããã«ã絶察æ°ã¯æžã£ãŠããã®ã«ãæåŸ å€ãšã®å·®ã ããåãåã£ãŠãå¢ããããšè¡šçŸãããäŸã¯ãå°ãªããªãã®ã§ãã
ãã®3ã€ãæèããã ãã§ãSNSäžã®ãååã ãæ¬åœãã®æ å ±ã«æ¯ãåãããå Žé¢ã¯ãé©ãã»ã©æžã£ãŠãããŸãã
çµããã«
æ
å ±ãçãããšã¯ã決ããŠåŸãåããªè¡çºã§ã¯ãããŸããããããã倧åãªäººãå®ãããã®ãååããªãã£ã¬ã³ãžã ãšãç§ã¯æããŠããŸãã
æåŸã«ã仿¥ãäŒããããã£ãããšãæŽçãããŠãã ããã
ã»ããŒãžãã¢å·ã®ç ç©¶ã¯ãHPVã¯ã¯ãã³ãåå®®é žãããå¢ãããããšã瀺ãããã®ã§ã¯ãããŸããã
ã»ç ç©¶ã瀺ããã®ã¯ã矩ååãšããæ¿çããæåŸ
ããã远å ã®äºé²å¹æãçºæ®ã§ããªãã£ãå¯èœæ§ã§ãã
ã»20ã24æ³ã®åå®®é žãã眹æ£çãã®ãã®ã¯ãããŒãžãã¢å·ã§ãä»å·ã§ããæéãšãšãã«æžå°ããŠããŸãã
ã»åäžå·ã»çãèŠ³å¯æéã»åžå°çŸæ£ãšããããŒã¿ã®æ§è³ªäžãçµæã®è§£éã«ã¯æ
éããå¿
èŠã§ãã
ã»HPVã¯ã¯ãã³ãã®ãã®ã®åå®®é žããäºé²å¹æã¯ããããŸã§ã®å€ãã®ç ç©¶ã§ç¢ºèªãããŠããŸãã
æ¡æ£ãããŠãããã®æçš¿ãããã®ãŸãŸä¿¡ããå¿ èŠã¯ãããŸãããããšãã£ãŠãé ããªãã«åŠå®ããå¿ èŠããªããšãç§ã¯æããŸããæ°åã®æå³ããäžç·ã«äžã€ãã€ç¢ºãããŠããããã®å§¿å¢ããããã°ãããªãã¯ããããã«æ¯ãåãããåŽã§ã¯ãªããæ£ããåãçŽããåŽã«å€ãã£ãŠããã¯ãã§ãã
â åç §å (æ€èšŒå¯èœæ§ã®ããã«)
ã»æ¬è«æïŒ"Causal inference, cancer registry data, and a single state policy change: Evaluating Virginia's HPV vaccine mandate"ïŒPubMed ID: 42442540ïŒScienceDirectæ²èŒïŒ https://pubmed.ncbi.nlm.nih.gov/42442540/ https://www.sciencedirect.com/science/article/pii/S2213538326000780
ã»çŸ©ååãšæ¥çš®çã®é¢ä¿ãæ€èšŒããå è¡ç ç©¶ïŒPierre-Victor D, Page TF, Trepka MJ, Stephens DP, Li T, Madhivanan P. "Impact of Virginia's School-Entry Vaccine Mandate on Human Papillomavirus Vaccination Among 13-17-Year-Old Females." J Womens Health. 2017. https://journals.sagepub.com/doi/pdf/10.1089/jwh.2016.5869
æ°ã«ãªãç¹ãã質åãããã°ãã³ã¡ã³ãæ¬ã§ãç¥ãããã ããããããŸã§èªãã§ãã ãã£ãããšã«æè¬ããããŸããããããšãããããŸããã
#HPVã¯ã¯ãã³ #åå®®é žãã #ãã¡ã¯ããã§ã㯠#æ å ±ãªãã©ã·ãŒ #å»çãã
ãããªãšæã£ããå¿æŽãããïŒ
ãããããã°å¿æŽãé¡ãããŸããããã ãããããã¯ãå·çã®ããã®æžç±è³Œå
¥ããAIã®ããã«äœ¿ãããŠããã ããŸãã